GSK Completes Acquisition of RAPT Therapeutics
March 04, 2026
March 04, 2026
LONDON, England, March 4 -- GSK (formerly GlaxoSmithKline), a biopharmaceutical company, issued the following news release on March 3, 2026:
* * *
GSK completes acquisition of RAPT Therapeutics
GSK plc (LSE/NYSE: GSK) today announced the completion of its previously announced acquisition of RAPT Therapeutics, a California-based, clinical-stage biopharmaceutical company dedicated to developing novel therapies for patients living with inflammatory and immunol . . .
* * *
GSK completes acquisition of RAPT Therapeutics
GSK plc (LSE/NYSE: GSK) today announced the completion of its previously announced acquisition of RAPT Therapeutics, a California-based, clinical-stage biopharmaceutical company dedicated to developing novel therapies for patients living with inflammatory and immunol . . .